Herbal Composition Enhances Insulin Sensitivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for type II diabetes, particularly insulin sensitizers, have limited effectiveness and are associated with side effects such as pancreas failure and liver toxicity, highlighting the need for alternative compositions that can improve insulin sensitivity without adverse effects.
Innovation Solution
A pharmaceutical composition comprising Ramulus Cinnamomi, Radix et Rhizoma Rhei, Semen Persicae, Radix Rhizoma Glycyrrhizae, and Cordyceps, which enhances insulin sensitivity by increasing insulin receptor binding, reducing blood sugar levels, and stimulating GLUT4 gene expression, thereby treating type II diabetes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional insulin sensitizers are used to treat type II diabetes, then blood sugar control is achieved, but side effects such as pancreas failure and liver toxicity occur
Solution Approach 1:
The patent changes the chemical composition parameters by using a specific formula of Chinese herbal ingredients (Cinnamomi Ramulus, Rhei Radix et Rhizoma, Persicae Semen, Glycyrrhizae Radix et Rhizoma, and Cordyceps) instead of conventional Western insulin sensitizers. This parameter change achieves blood sugar control while avoiding the harmful side effects of pancreas failure and liver toxicity associated with conventional drugs.
Solution Approach 2:
The patent employs a composite material approach by combining multiple Chinese herbal ingredients in a specific ratio (Cinnamomi Ramulus 15-25%, Rhei Radix et Rhizoma 30-40%, Persicae Semen 15-25%, Glycyrrhizae Radix et Rhizoma 15-25%, and Cordyceps 5-10%). This composite formulation synergistically improves insulin sensitivity and controls blood sugar without the severe side effects of single-agent conventional drugs.
2Duration of action of stationary object
If long term administration of insulin sensitizers is performed, then diabetes control is maintained, but pancreas failure and other side effects occur
Solution Approach 1:
The patent provides continuous useful action through long-term administration of the Chinese herbal composition that maintains insulin sensitivity and blood sugar control without accumulating toxic effects. The formulation's natural ingredients work continuously to improve insulin receptor binding and GLUT4 gene expression without the progressive damage to pancreatic cells caused by conventional insulin sensitizers.
Solution Approach 2:
The patent uses natural, biodegradable Chinese herbal ingredients that can be safely administered long-term without causing cumulative toxicity. These natural substances act as temporary, non-permanent interventions that resolve the diabetes issue without the permanent damage to pancreatic function caused by synthetic insulin sensitizers.
3Reliability
If conventional drugs for decreasing blood sugar level are used, then blood sugar control is achieved, but insulin sensitivity is limited
Solution Approach 1:
The patent changes the mechanism of action parameters by focusing on improving insulin sensitivity through natural herbal ingredients rather than simply decreasing blood sugar. The formulation enhances insulin receptor binding and stimulates GLUT4 gene expression, creating a more adaptable and versatile approach to diabetes treatment that addresses the root cause rather than just the symptom.
Data Source
AI summary
The present invention provides a pharmaceutical composition for treating diabetes comprising Ramulus Cinnamomi, Radix et Rhizoma Rhei, Semen Persicae, Radix Rhizoma Glycyrrhizae, and Cordyceps. The use of the composition for the manufacture of a medicament for treating type II diabetes is also provided.